ALX Oncology Announces Initiation of Phase 2 Investigator-Sponsored Trial of Neoadjuvant Radiation and Evorpacept in Combination With Pembrolizumab in Patients With Untreated Hpv-Mediated Oropharyngeal Cancer
ALX Oncology宣佈啓動由研究者贊助的新輔助放射和Evorpacept與Pembrolizumab聯合治療未經治療的HPV介導的口咽癌患者的2期試驗